HMMR and breast carcinoma: High HMMR expression indicated a reduced OS for bladder carcinoma, breast cancer, esophageal adenocarcinoma, head-neck squamous cell carcinoma, kidney renal clear cell carcinoma, kidney renal papillary cell carcinoma, liver hepatocellular carcinoma, lung adenocarcinoma, pancreatic ductal adenocarcinoma, sarcoma, and stomach adenocarcinoma.